FDA approves drug for treating postpartum depression


I’M GLEN MILLS. Surae: I’M SURAE CHINN. IN A HEALTH ALERT NOW, POSSIBLE HOPE FOR WOMEN WHO SUFFER FROM POSTPARTUM DEPRESSION. IN UTAH, ONE IN SEVEN WOMEN WILL SUFFER FROM IT. NOW, FOR THE FIRST TIME, THE FDA HAS APPROVED A MEDICATION SPECIFICALLY TO TREAT NEW MOMS WHO SUFFER FROM POSTPARTUM DEPRESSION. BUT IT COMES WITH A HEFTY PRICE TAG. A MEDICAL BREAK THROUGH IS GIVING HOPE TO WOMEN WITH POSTPARTUM DEPRESSION. THIS DRUG, HISTORIC. IT’S THE FIRST DRUG EVER TO BE APPROVED BY THE FDA TO TREAT POSTPARTUM DEPRESSION. THIS ONE, THE RESULTS ARE IMMEDIATE. Surae: WOMEN LIKE STEPHANIE HATHAWAY. I WAS UNABLE TO MAKE MYSELF COOK. UNABLE TO MAKE MYSELF CLEAN. VERY DIFFICULT TO TAKE CARE OF THE BABY. Surae: STEPHANIE SUFFERED FROM CRIPPLING POSTPARTUM DEPRESSION FOLLOWING BOTH OF HER PREGNANCIES. WHEN ANTIDEPRESSANTS FAILED TO HELP AFTER HER SECOND BIRTH, THE 33 YEAR-OLD DECIDE TODAY TAKE PART IN A STUDY FOR A NEW DRUG. THE FIRST EVER MEDICATION FOR WOMEN SUFFERING FROM POSTPARTUM DEPRESSION. THE DRUG REQUIRES A 2.5-DAY HOSPITAL STAY WHILE IT’S ADMINISTERED THROUGH A SINGLE 60-HOUR IV INFUSION. STEPHANIE SAYS SHE BEGAN TO FEEL BETTER WITHIN JUST A FEW HOURS. I JUST REMEMBER MY HUSBAND SAYING, WOW, I HAVEN’T HEARD THE YOU IN YOUR VOICE IN SO LONG. Surae: THE MEDICATION WORKS BY TARGETING A UNIQUE SET OF RECEPTORS IN THE BRAIN DIFFERENT FROM THE ONES TARGETED BY TRADITIONAL ANTIDEPRESSANT MEDICATIONS. SIDE EFFECTS INCLUDE LOSS OF CONSCIOUSNESS. DR. ASHTON SAYS THE BIGGEST ISSUE WITH THE NEW DRUG IS COST. THE DRUG COMES UP WITH UP TO A $35,000 PER DOSE PRICE TAG. MEDICAID AND INSURANCE, WILL THEY COVER IT? AS A PRACTICING PHYSICIAN, I CAN’T IMAGINE THAT THEY WILL. Surae: NOW, IF YOU ARE WORRIED YOU OR SOMEONE YOU KNOW

Leave a Reply

Your email address will not be published. Required fields are marked *